Apellis Pharmaceuticals shares are trading lower after multiple firms lowered their respective price targets on the stock.
Portfolio Pulse from Benzinga Newsdesk
Shares of Apellis Pharmaceuticals are trading lower after several firms reduced their price targets on the stock.
July 20, 2023 | 7:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Apellis Pharmaceuticals' stock is trading lower due to lowered price targets by multiple firms.
The lowered price targets by multiple firms indicate a negative outlook on the company's stock, which has led to a decrease in the stock price. This is directly impacting Apellis Pharmaceuticals' stock value in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100